GlassScriptPhysician profile
Mark D Khorsandi
NPI 1023051307
$10,194.77
in general payments reported to CMS, 2019-2025
44 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,310 · 2020: $2,795 · 2021: $1,057 · 2022: $1,277 · 2023: $1,515 · 2024: $1,179 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,379 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,379.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $375.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,439.01 | 2021-2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $1,989.04 | 2020 | |
| Allergan, INC. | $885.99 | 2019-2022 | |
| Seaspine Orthopedics Corporation | $558.70 | 2019 | |
| Lundbeck LLC | $516.75 | 2020-2025 | Vyepti |
| Pfizer INC. | $455.37 | 2023-2025 | |
| Amgen INC. | $277.62 | 2019-2025 | Krystexxa |
| Teva Pharmaceuticals USA, INC. | $252.78 | 2019-2022 | |
| Axogen | $239.71 | 2019-2025 | Avance Nerve Graft |
| Extremity Medical | $187.57 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $178.94 | 2020-2021 | |
| Merz North America, INC. | $173.22 | 2022-2023 | Xeomin |
| Kowa Pharmaceuticals America, INC. | $165.96 | 2022-2023 | Seglentis |
| Stryker Corporation | $142.07 | 2019-2024 | Easy Clip |
| Novartis Pharmaceuticals Corporation | $137.56 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Khorsandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.